Comparison of the Efficacy of Acupressure P6 Point, Dexamethasone and Ondansetron Versus Palonosetron Monotherapy for Preventing Postoperative Nausea and Vomiting in Laparoscopic Surgery
1 other identifier
interventional
90
1 country
2
Brief Summary
Postoperative nausea and vomiting (PONV) is defined as nausea and/or vomiting occurring within 24 hours after surgery, it commonly affects 20-30% patients but as high as 70-80% patients who are deemed high risk for PONV may be affected. PONV may cause unpleasant complications such as dehydration, electrolyte imbalance, suture dehiscence, aspiration of gastric contents, delayed recovery and prolonged hospital stay. Standard guideline recommended combination of anti-emetics to prevent PONV in high risk patients. The commonly used agents are dexamethasone and ondansetron which are cheaper although they are proven to be less effective as single agent when compared with newer agent such as palonosetron. As an adjunct or alternative to pharmacological treatment, acupressure P6 point has gained increasing attention for its possible value in preventing PONV. It is proven that acupressure reduced the incidences of PONV when combined with pharmacological treatment. It is postulated that acupressure active Aβ and Aδ fibres and stimulate the release of β-endorphine from hypothalamus. In addition, it is believed that acupressure might act on dopaminergic, serotonergic and norepinerphrinergic fibres which might has a role in PONV prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2020
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2020
CompletedStudy Start
First participant enrolled
July 6, 2020
CompletedFirst Posted
Study publicly available on registry
July 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedMay 1, 2024
April 1, 2024
1.3 years
April 15, 2020
April 30, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
The incidence of postoperative nausea and vomiting immediately, at
Hours 6, postoperative.
The incidence of postoperative nausea and vomiting immediately, at
Hours 12, postoperative
The incidence of postoperative nausea and vomiting immediately, at
Hours 24, postoperative
The incidence of postoperative nausea and vomiting immediately, at
Hours 48, postoperative
Secondary Outcomes (4)
The proportion of patients require rescue anti-emetics immediately,
at Hours 6, postoperative.
The proportion of patients require rescue anti-emetics immediately,
Hours 12, postoperative.
The proportion of patients require rescue anti-emetics immediately,
Hours 24, postoperative.
The proportion of patients require rescue anti-emetics immediately,
Hours 48, postoperative.
Study Arms (2)
Group I
EXPERIMENTALGroup I (n=45) 1. Acupressure wristband 2. IV Dexamethasone 8mg 3. IV Ondansetron 4mg
Group II
ACTIVE COMPARATORGroup II (n=45) 1\. IV Palonosetron 0.075mg
Interventions
Group 1 Patients with odd numbers labelled form will be Group I patients. They will receive intravenous dexamethasone 8mg during induction. Acupressure P6 wristband is applied after induction and removed prior to emergence to maintain blinding. Intravenous ondansetron 4mg is given prior to skin closure. Group 11 Patients with even numbers labelled form will be Group II patients who will receive intravenous palonosetron 0.075mg during induction.
Eligibility Criteria
You may qualify if:
- ASA I or II female patients aged 18 - 65 years old in view female patients are at higher risk of postoperative nausea and vomiting.
- Patients undergoing laparoscopic surgery.
- High risk for PONV (APFEL score 3-4).
You may not qualify if:
- Patients with known allergic to dexamethasone, ondansetron and wristband.
- Patients who take anti-emetic, emetogenic drugs and glucocorticoids within 24 hours before surgery.
- Patients with upper limb disability which affect the application of wristband.
- Obese patients with BMI \> 35 in view acupressure P6 wristband might be too tight to fit patient's wrist which might affect the correct placement of pressure point.
- Pre-existing vertigo
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Mohd Zulfakar Mazlan, MBBS
Kota Bharu, Kelantan, 16150, Malaysia
Mohd Zulfakar Mazlan
Kota Bharu, Kelantan, 16150, Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Potential patients are identified and consented for study during pre-operative assessment. Both patients and assessors are blinded in this trial. Participants and assessors are being blinded of the treatment or medications given intra-operatively. The acupressure wristband and anti-emetics will be given after general anaesthesia. The wristband will be removed prior to emergence, participants will not aware of the methods used to prevent nausea and vomiting. Postoperative participants will be assessed by independent nurses who are not involved in the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Comparison of the efficacy of acupressure P6 point, dexamethasone and ondansetron versus palonosetron monotherapy for preventing postoperative nausea and vomiting in laparoscopic surgery
Study Record Dates
First Submitted
April 15, 2020
First Posted
July 8, 2020
Study Start
July 6, 2020
Primary Completion
November 1, 2021
Study Completion
November 1, 2021
Last Updated
May 1, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share